Abstract:Acrylamide intoxication produces peripheral neuropathy characterized by weakness and ataxia in both humans and experimental animals. Previous studies on animals of different ages and species indicate that the longest and largest nerves are affected earlier with the major pathology in the terminal parts of axons, i.e., distal axonopathy. However, several issues have remained elusive; for example, what are the earliest pathological changes? An equally intriguing question is whether younger animals are more susceptible to acrylamide than older animals. To address these issues, we compared the vulnerability to acrylamide of 3- and 8-week-old mice. These mice were intoxicated with acrylamide in drinking water (400 ppm). The sequence of intoxication could be categorized into three stages. In the initial stage, there was no visible weakness or ataxia. The only noticeable changes were poor performance on the rota-rod test and swelling of motor nerve terminals. Obvious weakness and ataxia of hindlimbs developed gradually (here designated as the early stage). The weakness and ataxia progressed at variable speeds in mice of different ages, and eventually the forelimbs (quadriparesis) were affected in the late stage. Each stage appeared earlier in 3-week-old mice than in 8-week-old mice (7.1 +/- 1.1 vs 15.6 +/- 4.0 days, P < 0.01 for the early stage; and 15.3 +/- 2.1 vs 31.7 +/- 6.0 days, P < 0.01 for the late stage). The progression of neurological deficits was also faster in the younger mice (7.2 +/- 1.8 vs 16.3 +/- 4.2 days, P < 0.01). Pathological changes in the distal parts of motor nerves innervating hindfoot muscles were evaluated by combined cholinesterase histochemistry and immunocytochemistry for neuronal markers to demonstrate motor nerve terminals and neuromuscular junctions simultaneously. In the initial stage, there was axonal swelling in motor nerve terminals. As acrylamide intoxication continued, axonal swelling extended into junctional folds and into the intramuscular nerves, which resulted in Wallerian-like degeneration. Our results indicate that younger mice show a much higher susceptibility to acrylamide intoxication, and pathological changes precede neurological symptoms.

Acrylamide Induces Locomotor Defects And Degeneration Of Dopamine Neurons In Caenorhabditis Elegans

Subchronic exposure to acrylamide caused behaviour disorders and related pathological and molecular changes in rat cerebellum

Chronic acrylamide exposure resulted in dopaminergic neuron loss, neuroinflammation and motor impairment in rats

[Effects of Acrylamide on Synaptic Plasticity of Rat Neuron].

Transgenerational and parental impacts of acrylamide exposure on Caenorhabditis elegans: Physiological, behavioral, and genetic mechanisms

Effect of long-term exposure to acrylamide on endoplasmic reticulum stress and autophagy in rat cerebellum

Unraveling the Serum Metabolomic Profile of Acrylamide-Induced Cardiovascular Toxicity

Age-dependent acrylamide neurotoxicity in mice: morphology, physiology, and function

Acrylamide causes neurotoxicity by inhibiting glycolysis and causing the accumulation of carbonyl compounds in BV2 microglial cells

Acrylamide-induced peripheral neuropathy: manifestations, mechanisms, and potential treatment modalities

Acrylamide-induced damage to postsynaptic plasticity is CYP2E1 dependent in an SH-SY5Y co-culture system

Cytotoxic effects of acrylamide in nerve growth factor or fibroblast growth factor 1-induced neurite outgrowth in PC12 cells

The influence of systemic factors on acrylamide-induced changes in brain, nerve, and other tissues

Exposure to acrylamide induces skeletal developmental toxicity in zebrafish and rat embryos

The Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives

Toxic effects of subacute exposure to acrylamide on motor endplates of the gastrocnemius in rats

Acrylamide inhibits terminal sprouting triggered by botulinum toxin type A in rats

Tris(2-chloroethyl) phosphate (TCEP) and tris(2-chloropropyl) phosphate (TCPP) induce locomotor deficits and dopaminergic degeneration in Caenorhabditis elegans.

Acrylamide Induces Neurotoxicity in SH-SY5Y Cells via NLRP3-mediated Pyroptosis

Mechanistic progression of acrylamide neurotoxicity linked to neurodegeneration and mitigation strategies

Effect of oral exposure to acrylamide on biochemical and hematologic parameters in Wistar rats